BioVex news from FierceBiotech
NewsA deluge of pre-ASCO data hits the market
As we mentioned earlier this week, data from almost 5,000 clinical studies was released last night in preparation for next week's ASCO meeting. And some of the most interesting data won't be released Read more...
Zosano rounds up $45M in VC
Fremont, CA-based Zosano Pharma has received $45 million in its second round, bringing its total funding thus far to $90 million. Enterprise Associates, Nomura Phase4 Ventures, HBM BioVentures and Read more...
| Press ReleasesPRESS RELEASE: BioVex Closes Second Round of Series E Financing BioVex Closes Second Round of Series E Financing Second and Final Close Completes $35 Million Financing Woburn, MA, November 15 2007 – BioVex Inc, a clinical stage company developing new Read more... |
Paid Research Reports
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
- The Emerging Role of Postmarketing Clinical Research: Regulatory issues, strategic drivers and overall trends